\
peptides&elephants GmbH is a biotechnology and information technology startup based in Germany. Founded in 2001, the company specializes in providing customized peptides, antigen peptides, and peptide libraries for immunological research. Their flagship product, PEP-LIPS, offers high parallel customized peptide libraries and peptide pools. These products are approved for various applications including T-Cell Stimulation Assays, Epitope Mapping, EliSpot Assays, Drug Discovery, and Array Technology. peptides&elephants GmbH prides itself on offering a full range of peptides and peptidomimetics, from linear to cyclic, from short to overlong, and from crude to high purity. The company's dedication to quality, price, and support positions them as a reliable partner in the industry.
\For more information, interested parties can visit the company's website at www.peptides.de. peptides&elephants GmbH is represented by Dr. Oliver J. Kreuzer and can be contacted via telephone at +49 3302 2022000, fax at +49 3302 2022001, or email at [email protected]. The company is registered with the Court of Potsdam under the registration number HRB 15441 P and holds a VAT identification number of DE 218433508.
\While specific details about the company's last investment and investors are not available, peptides&elephants GmbH continues to play a vital role in the biotechnology and information technology sectors, leveraging their expertise to meet the needs of the immunological research market.
There is no investment information
No recent news or press coverage available for peptides&elephants GmbH.